ADC Therapeutics SA
Last updated September 27, 2026
Organization details
- Legal name
- ADC Therapeutics SA
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Switzerland
- Headquarters city
- Epalinges
- Headquarters country
- Switzerland
- Fiscal year end
- December
- Ticker symbol
- ADCT
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001771910
Board of directors
-
Ameet Mallik · Director · Chief Executive OfficerSince 2024
-
Jean-Pierre Bizzari · DirectorSince 2024
-
Peter Hug · DirectorSince 2024
-
Robert Azelby · DirectorSince 2024
-
Ron Squarer · DirectorSince 2024
-
Thomas Pfisterer · DirectorSince 2024
- Since 2025
-
Tyrell Rivers · DirectorSince 2024
-
Victor Sandor · DirectorSince 2024
-
Viviane Monges · DirectorSince 2024
Chief executives
Ameet Mallik
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 1, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.2%
-
98.9%
-
99.2%
-
99.3%
-
99.4%
-
99.4%
-
99.4%
-
99.4%
-
99.5%
Board connections
7 of this board's directors also sit on 14 other boards.
- via Ron Squarer and Timothy Coughlin
- via Victor Sandor
- via Jean-Pierre Bizzari
- via Ameet Mallik
- via Robert Azelby
- via Robert Azelby
- via Timothy Coughlin
- via Jean-Pierre Bizzari
- via Victor Sandor
- via Viviane Monges
- via Victor Sandor
- via Robert Azelby
- via Timothy Coughlin
- via Timothy Coughlin
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $19,641,067
- 6 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Ameet Mallik Director, Officer (Chief Executive Officer) | Grant or award | +675,000 | — | — |
| Jun 30, 2026 | Carmona Jose Officer (Chief Financial Officer) | Grant or award | +203,700 | — | — |
| Jun 30, 2026 | GRAHAM PETER J Officer (Chief Legal Officer) | Grant or award | +221,100 | — | — |
| Jun 30, 2026 | Zaki Mohamed Officer (Chief Medical Officer) | Grant or award | +213,900 | — | — |
| Jun 3, 2026 | Robert Azelby Director | Shares withheld for tax | −12,600 | $3.08 | $38,808 |
| Jun 3, 2026 | Ron Squarer Director | Shares withheld for tax | −15,196 | $3.08 | $46,804 |
| Jun 3, 2026 | Victor Sandor Director | Shares withheld for tax | −12,600 | $3.08 | $38,808 |
| Jun 3, 2026 | Viviane Monges Director | Shares withheld for tax | −2,596 | $3.08 | $7,996 |
| Jun 3, 2026 | Peter Hug Director | Shares withheld for tax | −2,156 | $3.08 | $6,640 |
| Jun 3, 2026 | Jean-Pierre Bizzari Director | Shares withheld for tax | −12,600 | $3.08 | $38,808 |
| Jun 3, 2026 | Timothy Coughlin Director | Shares withheld for tax | −12,600 | $3.08 | $38,808 |
| Jun 1, 2026 | Robert Azelby Director | Grant or award | +45,000 | — | — |
| Jun 1, 2026 | Ron Squarer Director | Grant or award | +45,000 | — | — |
| Jun 1, 2026 | Victor Sandor Director | Grant or award | +45,000 | — | — |
| Jun 1, 2026 | Viviane Monges Director | Grant or award | +45,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.